{"symbol": "ADAP", "companyName": "Adaptimmune Therapeutics plc", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.adaptimmune.com", "description": "Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.", "CEO": "James J. Noble", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}